Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)

Completed · Phase 1 · Has a placebo group

Conditions studied: Diabetes Prevention

In brief

Safety and tolerability of a soy-protein Russian Tarragon complex versus a placebo.

Key facts

Study ID
NCT02088203
Run by
Pennington Biomedical Research Center
People needed
64
Starts
2014-02-01
Expected to finish
2018-05-01
Last updated by the study team
2019-03-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.